Video Experimental Relacionado

Updated: Jul 15, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Las estatinas mejoran la capacidad migratoria mediante la regulación al alza del factor de unión repetida de los

Ioakim Spyridopoulos¹, Judith Haendeler, Carmen Urbich

¹Molecular Cardiology, Department of Internal Medicine IV, University of Frankfurt, Frankfurt, Germany.

|November 3, 2004

Resumen

Las estatinas previenen la senescencia de las células progenitoras endoteliales mediante la mejora de la proteína de captura de telómeros TRF2, preservando la función celular. Este estudio revela un nuevo efecto beneficioso de las estatinas sobre la biología de los telómeros y el potencial de la terapia celular.

Área de la Ciencia:

Biología celular Biología celular.
Biología Molecular Biología Molecular
Genética La genética.

Sus antecedentes:

Las células progenitoras endoteliales (EPC) experimentan senescencia replicativa durante el cultivo ex vivo, lo que limita su uso en la terapia celular.
La senescencia está relacionada con la disfunción de los telómeros, influenciada por el reloj mitótico y el estrés cultural.
El papel de la biología telomérica en el aumento funcional mediado por estatinas de las EPC requiere una aclaración.

Objetivo del estudio:

Investigar el papel de la biología de los telómeros en la mejora funcional inducida por estatinas de las células progenitoras endoteliales (EPC).
Para determinar si las estatinas pueden mitigar la senescencia prematura en EPCs cultivados.
Explorar el mecanismo por el cual las estatinas afectan la función de los telómeros y las EPC.

Principales métodos:

Los EPC humanos fueron aislados y cultivados.
La longitud de los telómeros se midió utilizando fluorescencia en hibridación in situ (Flow-FISH).
La expresión de TRF2 (factor de unión repetida de los telómeros) y Chk2 (checkpoint kinase 2) se evaluó a través de inmunoblotación y qRT-PCR.

Principales resultados:

Los EPC cultivados ex vivo no mostraron erosión de los telómeros.
El tratamiento con estatinas (atorvastatina, mevastatina) aumentó los niveles de proteína TRF2 sin alterar el ARNm, lo que sugiere una regulación posttranscripcional.
Las estatinas suprimían la inducción de Chk2, un marcador de la disfunción de los telómeros, y este efecto dependía de TRF2.

Conclusiones:

El cultivo ex vivo de EPC conduce a la "descapacitación" de los telómeros debido a la pérdida de TRF2.
Las estatinas previenen el deterioro funcional de la EPC a través de un mecanismo posttranscripcional dependiente de TRF2.
Este estudio demuestra un nuevo impacto beneficioso de las estatinas en la biología de los telómeros.

Más Videos Relacionados

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Videos de Conceptos Relacionados

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Cellular Membranes and Drug Transport

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.

Carrier-Mediated Transport

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...